Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimen
<p>Abstract</p> <p>Protease inhibitors (PIs) block HIV-1 maturation into an infectious virus particle by inhibiting the protease processing of gag and gag-pol precursor proteins. We have used a simple anti-HIV-1 p24 Western blot to monitor the processing of p55<sup>gag </s...
Main Authors: | Kuritzkes Daniel R, Mildvan Donna, Landay Alan, Lederman Michael M, Marozsan Andre J, Baird Heather A, Kessler Harold A, Arts Eric J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-04-01
|
Series: | AIDS Research and Therapy |
Subjects: | |
Online Access: | http://www.aidsrestherapy.com/content/2/1/2 |
Similar Items
-
Treatment Outcome and Regimens of Lipid-Lowering Drugs among HIV-Infected Patients Receiving Protease Inhibitors
by: Krisda Boonthos, et al.
Published: (2016-10-01) -
The Place of protease inhibitors in antiretroviral treatment
by: S.B. Tenore, et al. -
Influence of the Treatment Used in Inflammatory Bowel Disease on the Protease Activities
by: Dudzińska E, et al.
Published: (2020-12-01) -
Changes in non-specific proteases and their inhibitors in the course of acute purulent rhinosinusitis treatment with mucoactive drugs
by: A. A. Zavaliy, et al.
Published: (2017-04-01) -
Oral candidiasis in HIV+ patients under treatment with protease inhibitors
by: Andréa Lusvarghi Witzel, et al.
Published: (2008-12-01)